HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anthony J Coyle Selected Research

Immunoglobulin E (IgE)

6/2011Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice.
3/2009Acute, but not resolved, influenza A infection enhances susceptibility to house dust mite-induced allergic disease.
11/2007Impact of CD40 ligand, B cells, and mast cells in peanut-induced anaphylactic responses.
2/2005Cutaneous antigen priming via gene gun leads to skin-selective Th2 immune-inflammatory responses.
6/2003Evaluation of inducible costimulator/B7-related protein-1 as a therapeutic target in a murine model of allergic airway inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anthony J Coyle Research Topics

Disease

34Inflammation (Inflammations)
02/2016 - 02/2003
13Asthma (Bronchial Asthma)
01/2014 - 06/2003
10Infections
01/2014 - 01/2002
6Neoplasms (Cancer)
12/2015 - 02/2005
6Chronic Obstructive Pulmonary Disease (COPD)
04/2011 - 08/2006
5Respiratory Syncytial Virus Infections
04/2012 - 02/2006
5Autoimmune Diseases (Autoimmune Disease)
04/2011 - 01/2002
4Anaphylaxis (Anaphylactic Shock)
01/2013 - 02/2005
4Virus Diseases (Viral Diseases)
01/2011 - 05/2003
4Eosinophilia
10/2003 - 10/2002
3Fibrosis (Cirrhosis)
02/2016 - 11/2007
3Respiratory Hypersensitivity
01/2014 - 11/2007
3Rheumatoid Arthritis
08/2012 - 12/2004
3Experimental Arthritis
08/2012 - 12/2002
2Necrosis
08/2012 - 01/2002
2Arthritis (Polyarthritis)
08/2012 - 12/2002
2Human Influenza (Influenza)
01/2012 - 11/2006
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2011 - 02/2003
2Airway Remodeling
04/2011 - 02/2004
2Emphysema
02/2010 - 12/2005
2Pneumonia (Pneumonitis)
02/2010 - 12/2005
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2009 - 06/2009
2Bronchiolitis
04/2009 - 11/2008
2Hyperplasia
07/2004 - 02/2004
2Colitis
02/2004 - 02/2003
1Graft vs Host Disease (Graft-Versus-Host Disease)
02/2016
1Vascular System Injuries
02/2016
1Thrombosis (Thrombus)
01/2016
1Hemorrhage
01/2016
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2016
1Food Hypersensitivity (Food Allergy)
01/2013
1Dermatitis
11/2012

Drug/Important Bio-Agent (IBA)

18CytokinesIBA
04/2011 - 01/2002
7AllergensIBA
01/2014 - 02/2003
6ChemokinesIBA
06/2009 - 11/2003
5Monoclonal AntibodiesIBA
02/2016 - 11/2006
5Proteins (Proteins, Gene)FDA Link
04/2012 - 06/2003
5Immunoglobulin E (IgE)IBA
06/2011 - 06/2003
5Interleukin-13IBA
04/2011 - 10/2002
5OvalbuminIBA
04/2011 - 05/2003
5Antiviral Agents (Antivirals)IBA
01/2011 - 07/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010 - 01/2002
4CollagenIBA
02/2016 - 02/2004
4Immunoglobulin G (IgG)IBA
01/2016 - 02/2005
4ChitinasesIBA
04/2012 - 11/2007
4InterleukinsIBA
02/2010 - 01/2002
4NF-kappa B (NF-kB)IBA
08/2006 - 12/2002
4Interleukin-4 (Interleukin 4)IBA
02/2006 - 10/2002
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2014 - 05/2003
3DNA (Deoxyribonucleic Acid)IBA
10/2013 - 05/2007
3Interleukin-12 (IL 12)IBA
01/2013 - 02/2005
3SmokeIBA
04/2011 - 12/2005
3Interleukin-9 (Interleukin 9)IBA
04/2011 - 08/2009
3LigandsIBA
01/2011 - 11/2003
3Interleukin-5 (Interleukin 5)IBA
06/2010 - 10/2002
3Interferon Type IIBA
06/2009 - 07/2008
3Immunoglobulins (Immunoglobulin)IBA
06/2008 - 10/2002
3Transcription Factors (Transcription Factor)IBA
08/2006 - 12/2002
3Inducible T-Cell Co-Stimulator ProteinIBA
07/2004 - 06/2003
2InterferonsIBA
12/2012 - 01/2002
2Interleukin-6 (Interleukin 6)IBA
08/2012 - 05/2005
2Receptor for Advanced Glycation End ProductsIBA
04/2012 - 05/2010
2inebilizumabIBA
11/2011 - 10/2010
2Interleukin-1 (Interleukin 1)IBA
04/2011 - 01/2011
2Interleukin-18 (Interleukin 18)IBA
04/2011 - 06/2006
2Biomarkers (Surrogate Marker)IBA
04/2011 - 11/2009
2Messenger RNA (mRNA)IBA
12/2010 - 06/2009
2Biological ProductsIBA
06/2010 - 06/2008
2benralizumabIBA
06/2010 - 06/2010
2HMGB1 Protein (HMG1)IBA
05/2010 - 01/2010
2Interleukin-8 (Interleukin 8)IBA
02/2010 - 10/2008
2Interferon-alpha (Interferon Alfa)IBA
11/2009 - 06/2009
2B7 AntigensIBA
05/2007 - 02/2006
1Antifibrinolytic Agents (Antifibrinolytics)IBA
02/2016
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2016
1Plasminogen Activator Inhibitor 1IBA
02/2016
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2016
1Tissue Inhibitor of MetalloproteinasesIBA
02/2016
1Factor XIa (Coagulation Factor XIa)IBA
01/2016
1Factor XI (Plasma Thromboplastin Antecedent)IBA
01/2016
1butyl phosphorotrithioate (DEF)IBA
01/2016
1ErbB Receptors (EGF Receptor)IBA
12/2015
1Antineoplastic Agents (Antineoplastics)IBA
08/2015
1Immunoconjugates (Immunoconjugate)IBA
08/2015
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2014
1AntigensIBA
01/2014
1RNA (Ribonucleic Acid)IBA
10/2013
1AutoantigensIBA
10/2013
1OX40 LigandIBA
01/2013
1AutoantibodiesIBA
12/2012
1Imiquimod (Aldara)FDA LinkGeneric
11/2012
1Angiopoietin-2IBA
08/2012
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
08/2012
1AngiopoietinsIBA
08/2012
1TIE-2 Receptor (Receptor, TIE 2)IBA
08/2012
1Complement System Proteins (Complement)IBA
01/2012
1C-Type Lectins (C-Type Lectin)IBA
01/2012
1Calgranulin AIBA
01/2012
1CD AntigensIBA
11/2011

Therapy/Procedure

7Therapeutics
01/2011 - 12/2002